Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Jane
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JONES WILLIAM A JR
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McKenna Mark C.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bollinger Lisa
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fox Jennifer A.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shah Nimish P
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gottesdiener Andrew
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bollinger Lisa
Apogee Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Bollinger Lisa
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Apogee Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.99%),Fairmount Healthcare Fund II LP(9.99%), etc.
Apogee Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.3%),Peter Kolchinsky(5.3%), etc.
Apogee Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.25%),Deep Track Biotechnology Master Fund, Ltd.(6.25%), etc.
No Data
No Data